These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25648362)

  • 1. FIB-4 index for assessing the prognosis of hepatocellular carcinoma in patients with Child-Pugh class A liver function.
    Ito T; Kumada T; Toyoda H; Tada T
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1311-9. PubMed ID: 25648362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
    Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
    Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients.
    Tamaki N; Kurosaki M; Matsuda S; Muraoka M; Yasui Y; Suzuki S; Hosokawa T; Ueda K; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Asahina Y; Izumi N
    J Gastroenterol; 2014 Nov; 49(11):1495-503. PubMed ID: 24337828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the FIB-4 Index for hepatocarcinogenesis in hepatitis C virus carriers with normal alanine aminotransferase levels.
    Ito T; Kumada T; Toyoda H; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S
    J Viral Hepat; 2015 Oct; 22(10):777-83. PubMed ID: 25608086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection.
    Nishikawa H; Osaki Y; Komekado H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
    Oncol Rep; 2015 Jan; 33(1):88-94. PubMed ID: 25354477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.
    Tseng TC; Liu CJ; Su TH; Yang WT; Chen CL; Yang HC; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2017 Oct; 112(10):1564-1574. PubMed ID: 28853728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.
    Ito T; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Nishimura D; Toyoda H; Kumada T; Goto H; Hirooka Y
    J Gastroenterol Hepatol; 2019 Jan; 34(1):207-214. PubMed ID: 30144360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High liver fibrosis index FIB-4 is highly predictive of hepatocellular carcinoma in chronic hepatitis B carriers.
    Suh B; Park S; Shin DW; Yun JM; Yang HK; Yu SJ; Shin CI; Kim JS; Ahn E; Lee H; Park JH; Cho B
    Hepatology; 2015 Apr; 61(4):1261-8. PubMed ID: 25502481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic.
    Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Tanaka J
    J Gastroenterol Hepatol; 2017 Feb; 32(2):451-458. PubMed ID: 27288655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients.
    Park LS; Tate JP; Justice AC; Lo Re V; Lim JK; Bräu N; Brown ST; Butt AA; Gibert C; Goetz MB; Rimland D; Rodriguez-Barradas MC; Dubrow R
    Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2512-7. PubMed ID: 22028407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients.
    Abdelgawad IA
    J Clin Pathol; 2015 Feb; 68(2):154-60. PubMed ID: 25430496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIB-4 index serves as a noninvasive prognostic biomarker in patients with hepatocellular carcinoma: A meta-analysis.
    Zhang Y; Wang R; Yang X
    Medicine (Baltimore); 2018 Dec; 97(51):e13696. PubMed ID: 30572498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early cancer-related death after resection of hepatocellular carcinoma.
    Moriguchi M; Takayama T; Higaki T; Kimura Y; Yamazaki S; Nakayama H; Ohkubo T; Aramaki O
    Surgery; 2012 Feb; 151(2):232-7. PubMed ID: 21176935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index.
    Suh B; Yun JM; Park S; Shin DW; Lee TH; Yang HK; Ahn E; Lee H; Park JH; Cho B
    Cancer; 2015 Nov; 121(21):3818-25. PubMed ID: 26178294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.
    Patel J; Yopp A; Waljee AK; Singal AG
    J Clin Gastroenterol; 2016 Feb; 50(2):175-9. PubMed ID: 26125462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma.
    Xiao G; Zhu F; Wang M; Zhang H; Ye D; Yang J; Jiang L; Liu C; Yan L; Qin R
    Dig Liver Dis; 2016 Oct; 48(10):1220-6. PubMed ID: 27599803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.
    Berenguer J; Zamora FX; Aldámiz-Echevarría T; Von Wichmann MA; Crespo M; López-Aldeguer J; Carrero A; Montes M; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Barros C; Ortega E; Pulido F; Rubio R; Mallolas J; Tural C; Jusdado JJ; Pérez G; Díez C; Álvarez-Pellicer J; Esteban H; Bellón JM; González-García J;
    Clin Infect Dis; 2015 Mar; 60(6):950-8. PubMed ID: 25422386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
    Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
    Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.